SecBot SecBot
144 ·Filed Nov 12, 2026

MRK

Merck & Co., Inc.
NEUTRAL
Impact 2/10
Horizondays Processed4d 6h ago SEC0001950047-26-011026
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The filing is a routine advance notice of an insider sale; the actual sale may or may not occur. No material impact expected. Monitor for any subsequent Form 4 filings to confirm execution.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$147.76
T+0 close · Nov 12, 2026 · via day close
Latest settled
−2.23%
T+1 · $144.46
Vs SPY
−0.32%
α at T+1
Next horizon
T+5
in 3d
  1. T+0 · Nov 13 $147.76entry
  2. T+1 · 16h ago −2.23%α −0.32% · $144.46
  3. T+5 · in 3d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Richard R. DeLuca Jr., an officer of Merck, filed a Form 144 notice of intent to sell 58,185 shares of common stock, with an approximate market value of $8.6 million based on the filing date. The shares were acquired through exercise of options under a registered plan. The sale is a routine insider transaction and represents a small fraction of Merck's market cap.

Key Facts

  • Richard R. DeLuca Jr., an officer of Merck, filed Form 144 on 2026-11-12
  • Proposed sale of 58,185 shares of common stock
  • Estimated aggregate market value of $8,611,874.57
  • Shares acquired via exercise of options under a registered plan on 2026-11-12
  • Sale intended to be executed on NYSE
  • Prior sale of 11,699 shares on 2026-08-12 valued at $1,539,992.02

Financial Impact

Proposed sale of 58,185 shares valued at approximately $8.6 million, a small fraction of Merck's market cap

dilution

Risk Factors

  • Insider sale may signal personal liquidity needs rather than negative outlook
  • Sale is not yet executed; Form 144 is only an intent to sell

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-011026
Document: 0001950047-26-011026-index.html0001950047-26-011026
Document: 0001950047-26-011026.txt0001950047-26-011026

Track record

34 reports on MRK

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +16.92% at T+20 after the Aug 6, 2026 report. 6 of 7 went positive at some point.

Filters
  1. Nov 12, 20264d ago 144 Neutral 2/10 Viewing Entry $147.76 Now $144.46 −2.23% settles Feb 11
  2. Nov 9, 20268d ago PTAB Trial Neutral 2/10 Entry $148.05 Now $144.46 −2.42% settles Feb 8
  3. Nov 3, 202613d ago 3 Neutral 2/10 Entry $144.67 Now $144.46 −0.15% settles Feb 1
  4. Nov 3, 202613d ago Institutional Cluster Bearish 4/10 Entry $144.67 Now $144.46 +0.15% settles Feb 1
  5. Nov 2, 202614d ago 144 Neutral 2/10 Entry $144.67 Now $144.46 −0.15% settles Feb 1
  6. Oct 29, 202618d ago 8-K Neutral 5/10 Entry $146.33 Now $144.46 −1.28% settles Jan 27
  7. Oct 22, 202625d ago 3/A Neutral 1/10 Entry $145.27 Now $144.46 −0.56% settles Jan 21
  8. Oct 21, 202627d ago PTAB Trial Neutral 3/10 Entry $147.24 Now $144.46 −1.89% settles Jan 20
  9. Oct 15, 20264w ago PTAB Trial Bullish 6/10 Entry $145.95 Now $144.46 −1.02% settles Jan 13
  10. Oct 15, 20264w ago PTAB Trial Bullish 5/10 Entry $145.95 Now $144.46 −1.02% settles Jan 13
Showing 10 of 34

US Market Status

Market Closed · Opens Wed (10h 22m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026